4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
Anabel Fernández‐Iglesias(Hospital Clínic de Barcelona), Jordi Gracia‐Sancho(Institut d'Investigacions Biomèdiques de Barcelona)
Cited by 20
Related Papers
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
|Journal of Hepatology|2020|163
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
|Clinical Nutrition|2024|44